Polymorphisms of DNA Repair Genes and Risk of Glioma

DNA repair genes play a major role in maintaining genomic stability through different repair pathways that are mediated by cell cycle control genes such as p53. We found previously that glioma patients were susceptible to γ-ray-induced chromosomal breaks, which may be influenced by genetic variation in genes involved in DNA strand breaks, such as XRCC1 in single-strand break repair, XRCC3 and RAD51 in homologous recombination repair, and XRCC7 in nonhomologous end joining double-strand break repair. Therefore, we tested the hypothesis that genetic polymorphisms in XRCC1, XRCC3, RAD51, XRCC7, and p53 were associated with risk of glioma in 309 patients with newly diagnosed glioma and 342 cancer-free control participants frequency matched on age (±5 years), sex, and self-reported ethnicity. We did not find any statistically significant differences in the distributions of XRCC1 Arg399Gln, XRCC3 Thr241Met, RAD51 G135C, and P53 Arg72Pro polymorphisms between the cases and the controls. However, the XRCC7 G6721T variant T allele and TT genotype were more common in the cases (0.668 and 43.4%, respectively) than in the controls (0.613 and 38.9%, respectively), and the differences were statistically significant (P = 0.045 and 0.040, respectively). The adjusted odds ratios were 1.78 (95% confidence interval, 1.08–2.94) and 1.86 (95% confidence interval, 1.12–3.09) for the GT heterozygotes and TT homozygotes, respectively. The combined T variant genotype (GT+TT) was associated with a 1.82-fold increased risk of glioma (95% confidence interval, 1.13–2.93). These results suggest that the T allele may be a risk allele, and this XRCC7 polymorphism may be a marker for the susceptibility to glioma. Larger studies are needed to confirm our findings and unravel the underlying mechanisms.

[1]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[2]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[3]  K. Caldecott.  XRCC1 and DNA strand break repair. , 2003, DNA repair.

[4]  Hung-Ming Wang,et al.  The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  Anna Jakubowska,et al.  Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  D. Christiani,et al.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  E. Friedberg,et al.  DNA damage and repair , 2003, Nature.

[8]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  B. Glickman,et al.  Coding variants in human double-strand break DNA repair genes. , 2002, Mutation research.

[10]  Jeffrey E. Lee,et al.  DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  Hongbing Shen,et al.  P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. , 2002, Cancer letters.

[12]  Paul D P Pharoah,et al.  Variants in DNA double-strand break repair genes and breast cancer susceptibility. , 2002, Human molecular genetics.

[13]  M. Spitz,et al.  p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. , 2002, Journal of the National Cancer Institute.

[14]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  J. Bruner,et al.  γ-Radiation Sensitivity and Risk of Glioma , 2001 .

[16]  B. Modan,et al.  A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  Cody Schrank,et al.  American Cancer Society , 2005 .

[18]  C. Harris,et al.  Genetic polymorphisms in DNA repair genes and risk of lung cancer. , 2001, Carcinogenesis.

[19]  S. Eisenberg,et al.  A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Bruner,et al.  Gamma-radiation sensitivity and risk of glioma. , 2001, Journal of the National Cancer Institute.

[21]  L. Le Marchand,et al.  Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  D. Gell,et al.  A new X-ray sensitive CHO cell mutant of ionizing radiation group 7,XR-C2, that is defective in DSB repair but has only a mild defect in V(D)J recombination. , 2000, Mutation research.

[23]  A. Tomkinson,et al.  DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis , 1999, Oncogene.

[24]  M. Spitz,et al.  Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. , 1999, Carcinogenesis.

[25]  Derrick E. Rancourt,et al.  DNA-dependent protein kinase acts upstream of p53 in response to DNA damage , 1998, Nature.

[26]  J. Bruner,et al.  Mutagen sensitivity and risk of gliomas: a case-control analysis. , 1996, Cancer research.

[27]  D. Ward,et al.  Gene for the catalytic subunit of the human DNA-activated protein kinase maps to the site of the XRCC7 gene on chromosome 8. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Alt,et al.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation , 1995, Cell.

[29]  M. Linet,et al.  Etiology of brain tumors in adults. , 1995, Epidemiologic reviews.

[30]  D. Weaver,et al.  Complementation of V(D)J recombination defect and X-ray sensitivity of scid mouse cells by human chromosome 8. , 1994, Mutation research.

[31]  E. Stanbridge,et al.  Complementation of the radiosensitive phenotype in severe combined immunodeficient mice by human chromosome 8. , 1993, Cancer research.

[32]  N. Niikawa,et al.  Functional complementation in mouse-human radiation hybrids assigns the putative murine scid gene to the pericentric region of human chromosome 8. , 1993, Human molecular genetics.

[33]  K. Nakachi,et al.  Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. , 1993, Carcinogenesis.

[34]  B. Modan,et al.  Tumors of the brain and nervous system after radiotherapy in childhood. , 1988, The New England journal of medicine.

[35]  R. Hoover,et al.  Brain tumor mortality risk among men with electrical and electronics jobs: a case-control study. , 1987, Journal of the National Cancer Institute.

[36]  B. W. Lichtenstein,et al.  Neoplasms in the nervous system. , 1949 .